Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Imke, Matthys"'
Autor:
Delphine Mtf Vervloet, E Vanderstraeten, Pieter Dewint, Sébastien Kindt, Imke Matthys, Christophe Van Steenkiste, Sophia Steyaert, Peter Sinnaeve, Kristoff Cornelis, Daniel Borsboom, Valérie Lambrecht
Publikováno v:
Acta Clinica Belgica. 75:229-234
Mycoplasma pneumoniae infection can present with a plethora of symptoms and result in a systemic vasculitis by activating a cascade of autoimmune reactions. In this case report, a young man without relevant past medical history was admitted to the ho
Autor:
Justine Defreyne, Els Elaut, Annemieke Staphorsius, Baudewijntje P.C. Kreukels, Martin den Heijer, Guy T'Sjoen, Alessandra D. Fisher, Imke Matthys
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 296, p 296 (2021)
Journal of Clinical Medicine
Volume 10
Issue 2
Matthys, I, Defreyne, J, Elaut, E, Fisher, A D, Kreukels, B P C, Staphorsius, A, den Heijer, M & t’sjoen, G 2021, ' Positive and negative affect changes during gender-affirming hormonal treatment : Results from the European Network for the Investigation of Gender Incongruence (ENIGI) ', Clinical Chemistry, vol. 10, no. 2, 296, pp. 1-13 . https://doi.org/10.3390/jcm10020296, https://doi.org/10.3390/jcm10020296
Clinical Chemistry, 10(2):296, 1-13
JOURNAL OF CLINICAL MEDICINE
Journal of Clinical Medicine
Volume 10
Issue 2
Matthys, I, Defreyne, J, Elaut, E, Fisher, A D, Kreukels, B P C, Staphorsius, A, den Heijer, M & t’sjoen, G 2021, ' Positive and negative affect changes during gender-affirming hormonal treatment : Results from the European Network for the Investigation of Gender Incongruence (ENIGI) ', Clinical Chemistry, vol. 10, no. 2, 296, pp. 1-13 . https://doi.org/10.3390/jcm10020296, https://doi.org/10.3390/jcm10020296
Clinical Chemistry, 10(2):296, 1-13
JOURNAL OF CLINICAL MEDICINE
Improving transgender people&rsquo
s quality of life (QoL) is the most important goal of gender-affirming care. Prospective changes in affect can influence QoL. We aim to assess the impact of initiating gender-affirming hormonal treatment (HT) o
s quality of life (QoL) is the most important goal of gender-affirming care. Prospective changes in affect can influence QoL. We aim to assess the impact of initiating gender-affirming hormonal treatment (HT) o
Publikováno v:
Acta clinica Belgica. 75(4)
Dear Editor, We would like to comment on additional concerns that may rise about our manuscript ‘A plethora of manifestations following a Mycoplasma pneumoniae infection: a case report’[1]: 1. Rega...
Autor:
Imke, Matthys, Daniel, Borsboom, Sophia, Steyaert, Delphine, Vervloet, Kristoff, Cornelis, Erik, Vanderstraeten, Sébastien, Kindt, Pieter, Dewint, Valerie, Lambrecht, Peter, Sinnaeve, Christophe, Van Steenkiste
Publikováno v:
Acta clinica Belgica. 75(3)